Objective: The study aimed to assess the reliability and validity of the IPOS-Pol for patient self-reporting.

Method: Patients (>18 years of age) with advanced cancer admitted to three palliative care centers (inpatient units and home-based) were recruited to a multicenter, cross-sectional, observational, prospective study. Participants provided responses to the IPOS-Pol Patient version and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 15 - Palliative Care (EORTC QLQ-C15-PAL) Polish version at baseline (T1) and four to seven days later (T2). We assessed test-retest reliability, internal consistency, and construct validity of the tool.

Results: One hundred and eighty patients were included. Test-retest reliability demonstrated no statistically significant differences in the average outcomes of the IPOS-Pol between T1 and T2 (27.2 ± 9.2 vs. 26.5 ± 8.7; > 0.05). The intra-class correlation coefficient between T1 and T2 was = 0.83 ( < 0.0001), the intra-class correlation coefficient for test-retest reliability of the IPOS-Pol items ranged from 0.63 to 0.84 ( < 0.0001), and the Cronbach's coefficient for internal consistency was 0.773. The correlation coefficient between the IPOS-Pol and EORTC QLQ-C15-PAL total score was 0.79 ( < 0.001).

Significance Of Results: The patient version of the Polish adaptation of IPOS is a valid and reliable outcome measure for assessing symptoms and concerns of individuals receiving palliative care, as well as the quality of care provided.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951521001176DOI Listing

Publication Analysis

Top Keywords

palliative care
16
test-retest reliability
12
correlation coefficient
12
ipos-pol patient
8
patient version
8
eortc qlq-c15-pal
8
internal consistency
8
intra-class correlation
8
ipos-pol
6
care
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!